Bayesian Capital Management’s Helmerich & Payne HP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,400
Closed -$230K 311
2025
Q3
$230K Buy
+10,400
New +$192K 0.05% 438
2024
Q4
Sell
-17,900
Closed -$545K 818
2024
Q3
$545K Buy
+17,900
New +$618K 0.06% 355
2024
Q2
Sell
-19,900
Closed -$837K 903
2024
Q1
$837K Buy
+19,900
New +$753K 0.08% 327
2023
Q4
Sell
-10,700
Closed -$451K 873
2023
Q3
$451K Buy
+10,700
New +$447K 0.05% 393
2022
Q2
Sell
-14,400
Closed -$616K 907
2022
Q1
$616K Buy
+14,400
New +$496K 0.09% 323
2020
Q3
Sell
-12,000
Closed -$234K 591
2020
Q2
$234K Sell
12,000
-32,900
-73% -$641K 0.05% 406
2020
Q1
$703K Buy
+44,900
New +$1.58M 0.15% 204
2019
Q4
Sell
-5,200
Closed -$208K 667
2019
Q3
$208K Buy
5,200
+738
+17% +$32.6K 0.04% 439
2019
Q2
$226K Buy
+4,462
New +$246K 0.05% 418
2019
Q1
Sell
-9,946
Closed -$477K 645
2018
Q4
$477K Buy
+9,946
New +$611K 0.1% 294
2018
Q2
Sell
-4,500
Closed -$300K 649
2018
Q1
$300K Buy
+4,500
New +$304K 0.08% 396

Other funds holding HP

Bayesian Capital Management's HP Position: Q4 2025 in Review

Bayesian Capital Management sold out of Helmerich & Payne (HP) in Q4 2025, closing a stake of 10,400 shares — an estimated $230K sold.

Bayesian Capital Management first reported a position in HP in Q1 2018 and held it in 11 quarters. The position peaked at $837K in Q1 2024. 360 funds tracked by Wall St. Rank hold HP as of Q4 2025.

  • Bayesian Capital Management reported no remaining Helmerich & Payne position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 10,400 Helmerich & Payne shares in Q4 2025, an estimated $230K.
  • Bayesian Capital Management first reported a position in Helmerich & Payne in Q1 2018 and held it in 11 quarters.
  • Bayesian Capital Management's Helmerich & Payne position peaked at $837K in Q1 2024.
  • 360 funds tracked by Wall St. Rank held Helmerich & Payne as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.